G
Gareth J. Thomas
Researcher at University of Southampton
Publications - 252
Citations - 12287
Gareth J. Thomas is an academic researcher from University of Southampton. The author has contributed to research in topics: Cancer & Stromal cell. The author has an hindex of 58, co-authored 235 publications receiving 10358 citations. Previous affiliations of Gareth J. Thomas include Queen Victoria Hospital & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Mapping of a susceptibility locus for Crohn's disease on chromosome 16
Jean-Pierre Hugot,Pierre Laurent-Puig,Corinne Gower-Rousseau,J M Olson,James Lee,Laurent Beaugerie,I Naom,J.L. Dupas,A. Van Gossum,M Orholm,Catherine Bonaïti-Pellié,Jean Weissenbach,Christopher G. Mathew,J E Lennard-Jones,Antoine Cortot,Jean-Frederic Colombel,Gareth J. Thomas +16 more
TL;DR: A genome-wide search performed on two consecutive and independent panels of families with multiple affected members, using a non-parametric two-point sibling-pair linkage method, identified a putative CD-susceptibility locus on chromosome 16 which contains candidate genes which may be relevant to the pathogenic mechanism of inflammatory bowel diseases.
Journal ArticleDOI
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Nicolás Herranz,Suchira Gallage,Massimiliano Mellone,Torsten Wuestefeld,Sabrina Klotz,Christopher J. Hanley,Selina Raguz,Juan Carlos Acosta,Andrew J. Innes,Ana Banito,Athena Georgilis,Alex Montoya,Katharina Wolter,Gopuraja Dharmalingam,Peter Faull,Thomas L. Carroll,Juan Pedro Martinez-Barbera,Pedro R. Cutillas,Pedro R. Cutillas,Florian Reisinger,Mathias Heikenwalder,Mathias Heikenwalder,Richard A. Miller,Dominic J. Withers,Lars Zender,Gareth J. Thomas,Jesús Gil +26 more
TL;DR: A mechanism by which mTOR controls the SASP is reported by differentially regulating the translation of the MK2 (also known as MAPKAPK2) kinase through 4EBP1.
Journal ArticleDOI
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
Anusha-Preethi Ganesan,James Clarke,James Clarke,Oliver Wood,Eva M. Garrido-Martin,Serena J Chee,Toby Mellows,Daniela Samaniego-Castruita,Divya Singh,Grégory Seumois,Aiman Alzetani,Edwin Woo,Peter S. Friedmann,Emma King,Gareth J. Thomas,Tilman Sanchez-Elsner,Pandurangan Vijayanand,Pandurangan Vijayanand,Christian H. Ottensmeier +18 more
TL;DR: A greater density of TRM cells in tumors was predictive of a better survival outcome in lung cancer, and this effect was independent of that conferred by CTL density.
Journal ArticleDOI
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
M J Ward,S Thirdborough,Toby Mellows,Catherine L. Riley,Scott Harris,Krishna Suchak,Andrew Webb,C Hampton,Nimesh N. Patel,Connor Randall,H J Cox,Sanjay Jogai,John N. Primrose,Kim Piper,Christian H. Ottensmeier,Emma King,Gareth J. Thomas +16 more
TL;DR: The data suggest that an immune response, reflected by TIL levels in the primary tumour, has an important role in the improved survival seen in most HPV- positive patients, and is relevant for the clinical evaluation of HPV-positive OPSCC.
Journal ArticleDOI
Stromal features are predictive of disease mortality in oral cancer patients
Daniel Marsh,Krishna Suchak,Karwan A. Moutasim,S. Vallath,Colin Hopper,Waseem Jerjes,Tahwinder Upile,Nicholas Kalavrezos,Shelia M. Violette,Paul H. Weinreb,Kerry A. Chester,Jagdeep S. Chana,John Marshall,Ian R. Hart,Allan Hackshaw,Kim Piper,Gareth J. Thomas +16 more
TL;DR: This study highlights the limited prognostic value of TNM staging and suggests that an SMA‐positive, myofibroblastic stroma is the strongest predictor of OSCC mortality, regardless of disease stage.